Close

GSK (GSK) completes acquisition of TESARO (TSRO)

January 22, 2019 8:59 AM EST Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) today announced that it has successfully completed the acquisition of TESARO, Inc. (Nasdaq: TSRO) an oncology-focused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login